First human receives INBRAIN graphene brain interface during tumor surgery in Manchester

INBRAIN Neuroelectronics/Graphene brain interface

At Salford Royal Hospital in Greater Manchester, surgeons implanted INBRAIN Neuroelectronics' graphene-based brain interface on a patient during brain tumor removal, marking the first human use of graphene neural electrodes. The one-atom-thick carbon material enabled surgeons to distinguish healthy from cancerous tissue with micrometer-scale precision during the tumor resection procedure.

• First-in-human trial of graphene electrodes will enroll 8–10 patients primarily to establish safety; lead investigator Dr. David Coope (Manchester Centre for Clinical Neuroscience).
• Graphene's properties enable signal capture in areas where traditional metals and materials struggle with signal fidelity; ultradense electrode arrays at micrometer resolution.
• European Commission's Graphene Flagship project and University of Manchester sponsored the work; collaborative effort with Professor Kostas Kostarelos (Nanomedicine, Manchester).